Interface Wettability Transition‐Driven Drug Release and Dual‐Phase Functionalization in Implant Abutment
Advanced Science · 2026-07 · 13 (39)
DOI: 10.1002/advs.75351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.04.2026. Verfasst von Zhongchao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics & Oral Mucosal Diseases, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Wettability, Dental Abutments, Drug Liberation, Dental Implants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Bureau of Luzhou City, Affiliated Stomatological Hospital of Southwest Medical University, The Sichuan Medical Association.
Abstract (Originalsprache)
Dental implant abutments face dual clinical challenges of early‐stage biological contamination and late‐stage inflammatory microenvironments. To address the issues, this study developed a smart drug‐release coating based on a superhydrophobic‐wettable transition mechanism. The coating on the abutment surface was constructed by hydrophobic micelles self‐assembling on mesoporous silica nanoparticles loaded with berberine. In the early stage, the superhydrophobic surface can effectively resist the adhesion of proteins and bacteria. With protein deposition, this process induced a transition of the superhydrophobic surface to a hydrophilic state, leading to a sigmoidal drug release profile that passively triggered sustained microenvironment regulation in the later stage. In vivo experiments demonstrated that this coating not only had strong immediate antibacterial efficacy (22.5‐fold enhancement) but also significantly reduced inflammation and promoted soft tissue closure. This work provides a sequential functionalization strategy of “early‐antifouling‐enabled late active regulation” for abutments, offering a potential solution to prevent peri‑implant inflammation and soft tissue dehiscence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontics & Oral Mucosal Diseases, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Luzhou, Sichuan, China.
- Institute of Stomatology, Southwest Medical University, Luzhou, Sichuan, China.
- Department of Prosthodontics, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Department of Oral Radiology, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, P. R. China.
ORCID-Profile: Xiao Han, Dan Zou, Bingyang Lu, Liyuan Fan
Förderung
- Science and Technology Bureau of Luzhou City
- Affiliated Stomatological Hospital of Southwest Medical University
- The Sichuan Medical Association
Zitieren
APA
Wang, Z., Shi, L., Li, M., Han, X., Wang, J., Wang, G., Zou, D., Lu, B., & Fan, L. (2026). Interface Wettability Transition‐Driven Drug Release and Dual‐Phase Functionalization in Implant Abutment. Advanced Science, 13(39). https://doi.org/10.1002/advs.75351
Vancouver
Wang Z, Shi L, Li M, Han X, Wang J, Wang G, et al. Interface Wettability Transition‐Driven Drug Release and Dual‐Phase Functionalization in Implant Abutment. Advanced Science. 2026;13(39). doi:10.1002/advs.75351
BibTeX
@article{Wang2026,
author = {Wang, Zhongchao and Shi, Liang and Li, MingXia and Han, Xiao and Wang, Jinghan and Wang, Guangping and Zou, Dan and Lu, Bingyang and Fan, Liyuan},
title = {Interface Wettability Transition‐Driven Drug Release and Dual‐Phase Functionalization in Implant Abutment},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {39},
doi = {10.1002/advs.75351}
}
EUVIMED